androstenediol has been researched along with Disease Models, Animal in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Abdel-Tawab, AM; Bahaa, N; Khalifa, AE; Salama, RM; Schaalan, MF; Tadros, MG | 1 |
| Lendemans, S; Oberbeck, R; Schmitz, D | 1 |
| Falvo, RE; Pirmann, JC; Wade, DR; Winter, ML | 1 |
4 other study(ies) available for androstenediol and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Potential neuroprotective effect of androst-5-ene-3β, 17β-diol (ADIOL) on the striatum, and substantia nigra in Parkinson's disease rat model.
Topics: alpha-Synuclein; Androstenediol; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Estrogen Receptor beta; Inflammation Mediators; Male; Motor Activity; Neurons; Neuroprotective Agents; NF-kappa B; Parkinson Disease; Rats; Rats, Wistar; Rotenone; Substantia Nigra; Tyrosine 3-Monooxygenase | 2018 |
Androstenediol modulates sepsis induced alterations of survival and immune functions in a murine model of sepsis.
Topics: Administration, Intravenous; Androstenediol; Animals; Apoptosis; Body Temperature; Cytokines; Dehydroepiandrosterone; Disease Models, Animal; Dose-Response Relationship, Drug; Injections, Subcutaneous; Male; Mice; Mice, Inbred Strains; Molecular Conformation; Sepsis; Spleen; Survival Rate | 2014 |
A noninvasive technique for monitoring changes in canine prostatic size in vivo.
Topics: Androstenediol; Animals; Biometry; Disease Models, Animal; Dogs; Drug Administration Schedule; Estradiol; Laparotomy; Male; Organ Size; Prostate; Prostatic Hyperplasia; Triolein | 1981 |